Zoloft Pfizer

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zoloft Pfizer

Quick Facts

Property Description
Active ingredient Sertraline (as sertraline hydrochloride)
Form Tablets, Oral concentrate solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Modulation of mood and emotional balance
Origin Synthetic Small Molecule

What Type of Medicine is Zoloft (Sertraline)?

Zoloft is the brand name for this prescription-only medication, developed and initially marketed by Pfizer. The active ingredient is sertraline, which belongs to the widely clinically recognized class of Selective Serotonin Reuptake Inhibitors (SSRIs). This classification identifies it as a specific type of antidepressant medication. Sertraline is a synthetic Small Molecule recognized for its role in adjusting disrupted neurochemical pathways. The general understanding is that this medicine helps stabilize key chemical messengers necessary for mood regulation.

The drug's single-ingredient composition and focused pharmacological target differentiate it from older, less selective agents. This focused action contributes to its status as a core component in protocols for promoting emotional well-being.

Composition and Available Pharmaceutical Forms

The product relies solely on its active component, sertraline hydrochloride, and is classified as a single-ingredient product designed for oral administration. Zoloft is offered in two distinct dosage forms: solid tablets and a liquid oral concentrate solution. The availability of the oral concentrate solution is a specific feature, providing a flexible means of administration for patients who may have difficulty swallowing the tablets.

While the tablets integrate the active compound with pharmaceutical excipients, the concentrate uses an aqueous/alcoholic base. This medication type is primarily used to adjust certain processes in the central nervous system, ensuring the delivery of a standardized chemical agent.

What is the General Purpose of Sertraline?

The general purpose of sertraline is to help restore a balanced neural environment by increasing the availability of the neurotransmitter serotonin in the brain. The drug's mechanism involves the targeted inhibition of neuronal serotonin reuptake, resulting in potentiated serotonergic activity. This sustained adjustment of the chemical environment is the underlying benefit, assisting in the long-term maintenance of mental and emotional balance.

Regulatory References

  1. National Institute of Mental Health
  2. MedlinePlus Sertraline Entry

What side effects are possible with Zoloft Pfizer?

Possible Side Effects and Safety Information

The official safety profile for sertraline, the active ingredient in Zoloft, is formally classified by government regulatory authorities based on both clinical trial and post-marketing data. Adverse reactions are grouped by frequency and the physiological systems affected, such as Gastrointestinal Disorders, Nervous System Disorders, and Psychiatric Disorders.

Frequency-Classified Adverse Reactions

Regulatory documents classify certain events as Very Common (potentially affecting more than 1 in 10 individuals in some contexts), including nausea, diarrhea, insomnia, and fatigue. Common adverse reactions (potentially affecting up to 1 in 10) include tremor, decreased appetite, dizziness, and ejaculation failure in males. Events like Serotonin Syndrome, Hyponatremia, and QTc Prolongation are documented from post-marketing reports, meaning their frequency is Not Known.

Serious Safety Considerations

The prescribing information highlights several serious safety considerations. The risk of Suicidal Thoughts and Behaviors is explicitly documented, particularly in pediatric and young adult patients at the initiation of treatment or following dosage changes. Other major warnings include the potential for Serotonin Syndrome (a potentially life-threatening reaction) and an increased risk of Abnormal Bleeding or hemorrhage. Additionally, safety notes address the risk of Hyponatremia (low sodium levels), which is more frequently observed in older patients.

Population and Timing Patterns

The label specifies that safety observations must be made for Newborns following third-trimester exposure, noting the potential for persistent adverse reactions. The risk of clinical worsening is generally observed to be higher during the beginning of a course of therapy or when dose changes are implemented. Use is contraindicated within 14 days of taking a Monoamine Oxidase Inhibitor (MAOI) due to the documented risk of serious reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation on Sertraline (Zoloft) describes specific manifestations and the required emergency response in the event of an overdose. Overdose may present with documented clinical signs including somnolence, dizziness, tremor, nausea, vomiting, and tachycardia (rapid heart rate).


Documented Severe Outcomes and Required Actions

The most serious outcomes documented in regulatory warnings are Serotonin Syndrome (Serotonin Toxicity), seizures, coma, and severe cardiac electrophysiologic abnormalities, such as QTc interval prolongation and ventricular tachycardia. The official labeling mandates that individuals seek immediate medical attention or call emergency services for any suspected overdose due to the potential for these life-threatening events. Increased severity is associated with co-ingestion of other agents, including alcohol and other serotonergic drugs. Elderly patients and those with hepatic impairment are identified as having a greater risk for adverse effects.


Management and Antidote Status

Treatment is defined as symptomatic and supportive, aiming to maintain the airway and monitor vital signs. Procedures such as administering activated charcoal and gastric lavage may be considered shortly after ingestion. No specific antidote is known for Sertraline overdose, according to regulatory statements. Cardiac monitoring (ECG) and extended clinical monitoring are often required for severe cases.

Therapeutic Uses of Zoloft Pfizer

What Zoloft Pfizer Treats: Main Uses and Benefits

The therapeutic application of Zoloft (sertraline) is commonly used across domains where additional symptomatic support is needed for multiple mental health conditions. The medication is used for easing symptoms that interfere with daily comfort and create functional strain.

The primary conditions where this support is indicated include Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Posttraumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and the recurrent mood disruption of Premenstrual Dysphoric Disorder (PMDD). It is generally applied in clinical settings that involve unstable symptom patterns or phases when symptoms become more noticeable.

“The medication may assist with maintaining functional stability and can contribute to improved comfort during periods of heightened symptoms.”

It may provide support that helps ease the overall symptom burden of persistent sadness, pathological fear, and intrusive thoughts. This use may help patients cope more steadily with symptom fluctuations and may support general well-being during symptomatic phases.

Quick Fact: Supportive Management for Pathological Fear and Intrusive Thoughts The medicine may be commonly used to address symptom clusters related to recurrent, unexpected panic attacks and the demanding nature of obsessive-compulsive rituals.

Regulatory References

  1. NIH StatPearls overview of Sertraline uses

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Zoloft Pfizer — Official Regulatory Information

The eligibility profile for sertraline (Zoloft) is defined by official population-based criteria. Use is contraindicated in patients with a known hypersensitivity to the drug or who are concurrently using Irreversible Monoamine Oxidase Inhibitors (MAOIs), including linezolid and intravenous methylene blue. Co-administration with Pimozide is also prohibited.

Age Group Eligibility Status Key Restriction/Limitation
Adults (18+) Eligible Approved for all listed uses.
Pediatric (6–17) Restricted Eligibility Approved only for Obsessive-Compulsive Disorder.
Children (Under 6) Use Not Established Safety and efficacy are not established for any indication.

Use is not recommended in Severe Hepatic Impairment due to insufficient clinical data. However, Renal Impairment typically requires no dose adjustment. Caution is required for patients with a history of Mania/Hypomania or Seizure Disorders, and in elderly patients. Use during the third trimester of pregnancy may increase the risk of Persistent Pulmonary Hypertension of the Newborn (PPHN), and use during lactation requires careful consideration as the substance is excreted in breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile for Zoloft (sertraline) based on mandatory prohibitions and defined pharmacokinetic and pharmacodynamic risks.

Contraindicated Combinations

Certain agents are explicitly prohibited for co-administration. Co-administration with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Intravenous Methylene Blue, is contraindicated due to the high risk of Serotonin Syndrome. Pimozide is also contraindicated because sertraline can increase its plasma concentrations, posing a risk of QTc prolongation.

Interaction Type Interacting Substance Official Regulatory Statement
Timing-based Rule MAOIs (before or after) A mandatory 14-day washout period must elapse for switching in either direction.
Dosage Form Specific Disulfiram Contraindicated only with the Zoloft Oral Concentrate solution (due to alcohol content).

Documented Exposure and Pharmacodynamic Risks

Sertraline is a documented inhibitor of the CYP2D6 enzyme, which can increase the exposure of co-administered CYP2D6 substrates. Pharmacodynamic risk is identified when co-administered with other serotonergic agents (e.g., Triptans, St. John's wort), which potentiates the risk of Serotonin Syndrome. Co-administration with drugs that interfere with hemostasis, such as NSAIDs or Warfarin, is documented to increase the risk of bleeding. For the tablet form, food intake is officially documented to increase the maximum plasma concentration of sertraline. Caution is also noted for patients with Hepatic Impairment, where clearance is slowed, potentially increasing drug exposure.

Mechanism of Action

Selective Serotonin Reuptake Inhibition

Zoloft (sertraline) acts as a selective inhibitor of the Serotonin Transporter (SERT) protein, which is found on the presynaptic neuronal membrane. By binding to SERT, the drug prevents the reabsorption of the neurotransmitter serotonin (5-HT) from the synaptic cleft, resulting in an immediate increase in the local concentration of 5-HT. This initial molecular action enhances serotonergic signaling throughout the Central Nervous System.

Long-Term Neural Adaptive Cascades

Chronic SERT inhibition triggers adaptive changes in the serotonergic system. The sustained elevation of synaptic serotonin leads to the desensitization of inhibitory autoreceptors and the subsequent upregulation of neurotrophic factors, such as BDNF. This cascade promotes neuronal plasticity, which is associated with the modulation of neural circuits involved in emotional processing.

Modulation of Secondary Systems

Beyond its primary mechanism, sertraline also binds to the Sigma-1 (sigma1) receptor, which may influence intracellular pathways governing cellular stress and signaling. Additionally, the drug's mechanism affects peripheral systems by inhibiting serotonin uptake into platelets, thereby modulating platelet function, which is a physiological consequence of SERT blockade.

Dosage and Administration Information

How to Use Zoloft Pfizer (Sertraline) — Official Administration Guidelines

Sertraline is approved for oral administration using either the tablet or the liquid oral concentrate solution. The medicine is typically administered once daily. Zoloft tablets can be ingested with or without food. For the oral concentrate solution, immediate dilution is required using 4 ounces (1/2 cup) of approved liquids, such as water, ginger ale, lemonade, or orange juice; the concentrate must not be mixed with other liquids.


Dosing Protocol and Adjustments

Treatment is initiated at an official starting dose of 25 mg or 50 mg, depending on the specific condition. Dosage is modified (titrated) gradually, usually in increments of 25 mg to 50 mg at weekly intervals, up to a maximum official daily dose of 200 mg for most adult indications. The administration follows a long-term plan. When discontinuing treatment, the dosage must be gradually reduced over several weeks rather than stopped abruptly. If a dose is missed, patients are instructed not to take two doses at once but to resume the next scheduled dose at the usual time.


Special Use Conditions

Official guidelines specify procedural adjustments for certain populations. For patients with mild hepatic impairment, both the starting and maximum dosages are recommended to be half the standard dose. Additionally, administration for OCD in the pediatric population (ages 6–17) begins with a lower initial dose. If the capsule form is used, it must be swallowed whole and is not to be crushed or opened.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zoloft (Sertraline)

Research Evidence for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

Research was studied for Major Depressive Disorder (MDD) using numerous randomized controlled trials (RCTs) over defined time intervals. These studies were used in research exploring how symptoms change over time, monitoring outcomes related to systemic or functional imbalance. In maintenance studies, research examined the time elapsed until a new episode was reported. Research scenarios reported measurements related to the time elapsed until recurrence between groups continuing medication and comparison groups over the study period. One study of highly recurrent MDD examined the measured time elapsed until recurrence between groups continuing the medication and comparison groups over the 18-month trial. Research notes a lack of clarity on the duration required for the continuation phase after initial response.

Sertraline was evaluated in studies for Obsessive-Compulsive Disorder (OCD), including both short-term acute trials and extended-term protocols lasting well over a year. These trials examined outcomes reflecting daily functioning and the severity of OCD symptoms. Research on OCD was observed in both adults and the pediatric population. Extended trials describe score changes that were recorded over the second year of study. While long-term data exists, the necessary duration of treatment to prevent symptoms from returning is not fully established, and some historical research notes a higher rate of patient withdrawal in specific study designs.


Research Evidence for Panic Disorder (PD) and Social Anxiety Disorder (SAD)

Acute trials monitored measured differences in the frequency of panic attacks between the groups that continued medication and the placebo groups for Panic Disorder (PD). A key limitation is that patients with co-occurring major depression, OCD, or bipolar disorder were typically excluded from the main trials, meaning the results apply only to the populations studied. Research exploring Social Anxiety Disorder (SAD) examined patient-reported experiences and monitored changes in anxiety symptom severity. However, data for certain groups remain insufficient, as many pivotal efficacy studies historically excluded patients with significant co-occurring mental health conditions. Research focusing on long-term maintenance for SAD is limited.


Research Gaps and What Remains Uncertain about Sertraline

Long-term effects are not fully established for all approved conditions, and follow-up durations were limited in many acute studies. Data for certain groups remain insufficient, especially for patients with complex co-occurring mental health conditions, as many pivotal trials excluded these individuals. The research provides insight into short-term changes but does not determine whether an individual will respond similarly outside of the specific conditions under which the study results reflect. Comparative evidence, such as head-to-head trials against other similar medications for certain indications, remains insufficient in some areas of the research.

Key Studies & References

  1. NICE Guideline NG222: Depression in adults: treatment and management

Frequently Asked Questions (FAQ)

Common questions about Zoloft Pfizer (FAQ)

Q: What are the main things Zoloft is approved to treat?

According to official regulatory labeling, sertraline is approved to treat several conditions. These indications include Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Social Anxiety Disorder (SAD), and Premenstrual Dysphoric Disorder (PMDD).

Q: Why is Zoloft often prescribed for anxiety and not just depression?

Sertraline is approved for the treatment of several anxiety-related conditions beyond Major Depressive Disorder, according to official regulatory documents. These specific approved indications include Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD).

Q: Is Zoloft used to treat panic attacks?

Yes, regulatory documents confirm that sertraline is officially approved for the treatment of Panic Disorder (PD), a condition characterized by panic attacks.

Q: Can Zoloft be used for premenstrual dysphoric disorder (PMDD)?

Yes, according to the indications section of regulatory documents, sertraline is officially approved for the treatment of Premenstrual Dysphoric Disorder (PMDD).

Q: Is there a black box warning associated with Zoloft?

The U.S. FDA requires a Boxed Warning (often called a 'black box warning') for sertraline. This regulatory warning alerts patients and caregivers to the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults when starting treatment or following dose changes.

Q: Is Zoloft a controlled substance?

According to official regulatory sources, sertraline is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or other major international regulatory bodies.

Q: Does Zoloft have a potential for abuse or dependence?

Sertraline is not a controlled substance, which regulatory authorities associate with a low risk of abuse potential. However, official warnings regarding discontinuation syndrome (withdrawal symptoms) acknowledge the potential for physical dependence.

Q: How long does Zoloft stay in your system after you stop taking it?

Official pharmacokinetics (how the body handles the drug) information states that the average elimination half-life of sertraline is approximately 26 to 27 hours. This half-life indicates the time required for half the amount of the drug to be cleared from the plasma. Complete elimination is typically estimated to take about five to six half-lives.

Q: Can Zoloft affect my ability to drive or operate machinery?

Official documents caution that this medication may affect the mental and physical abilities needed to perform tasks that require alertness, such as driving a car or operating machinery. Patients are generally advised about this potential for impairment.

Q: Can Zoloft change how alcohol affects you?

Regulatory information cautions against the use of sertraline concurrently with alcohol. This is because the combination may potentiate the effects of alcohol.

Q: Are there any specific foods or drinks to avoid while taking Zoloft?

Official warnings address the use of alcohol while taking sertraline. Furthermore, regulatory documents specify that the liquid oral concentrate must only be mixed with four approved liquids (water, ginger ale, lemon/lime soda, or orange juice) immediately before use. Grapefruit juice has also been reported in official sources to potentially increase the amount of the drug in the body.

Q: Does Zoloft interact with grapefruit juice?

Official product information reports that grapefruit or grapefruit juice may interact with sertraline. This potential interaction can lead to increased levels of the drug in the body.

Q: Does Zoloft interact with birth control pills?

Official drug interaction studies indicate that there is no significant interaction between sertraline and combined oral contraceptives (birth control pills). Therefore, no dose adjustment is typically required for either medication.

Q: Why is Zoloft often started at a low dose?

The product labeling specifies that treatment is initiated at a low dose and then the dosage is gradually increased (titrated) over weekly intervals. This gradual approach is designed to help manage potential side effects and improve patient tolerability.

Q: Is it better to take Zoloft in the morning or the evening?

The product label specifies that sertraline should be administered once daily. While the exact time (morning or evening) is not mandated by the label, official guidance often notes that timing the dose can help manage common side effects like insomnia or sleepiness.

Q: What is the general expectation for how long it takes to feel the full effect of Zoloft?

Based on clinical trial evidence for its approved conditions, therapeutic effects are often measured over a period of several weeks (e.g., 6 to 12 weeks). This indicates that the full therapeutic effect of the medication is not typically felt immediately and requires chronic administration.

Q: Can you take Zoloft for just a few months, or is it always long-term?

Official guidelines describe administration as following a long-term plan. When discontinuing the medication, the product labeling details a protocol for gradual dose reduction over several weeks rather than abruptly stopping, which suggests short-term use is not the standard protocol.

Q: What is the typical time frame for side effects to appear when starting Zoloft?

Regulatory information states that the risk of clinical worsening and the emergence of side effects is generally observed to be higher during the beginning of a course of therapy.

Q: Is it normal to feel a little more anxious when first starting Zoloft?

Regulatory information notes that clinical worsening, which may include the emergence of symptoms like anxiety, agitation, and panic attacks, is possible during the initial phase of therapy or when the dosage is changed.

Q: Is it true that Zoloft can cause emotional flatness?

Official regulatory documents categorize adverse reactions into systems like psychiatric disorders and nervous system disorders. While specific terms like 'emotional flatness' or 'emotional blunting' may not appear in the most common side effect tables, general affective changes are related to the drug's mechanism of action.

Q: Can Zoloft cause weight gain or weight loss?

Regulatory data may report effects on body weight. Specifically, decreased appetite is a reported effect, and decreased weight has been reported in clinical trials involving children. Conversely, weight gain has also been reported in clinical trials, particularly with long-term use.

Q: Is Zoloft commonly associated with headaches?

Official product information from major regulatory labels lists headache as a common or very common adverse reaction associated with taking sertraline.

Q: Does Zoloft cause dry mouth?

Official product information confirms that dry mouth (Xerostomia) is explicitly listed as a common adverse reaction associated with sertraline.

Q: Can Zoloft cause vivid dreams or sleep disturbances?

Official adverse reaction lists include insomnia (difficulty sleeping) as a very common effect. Other sleep disturbances, such as abnormal dreams, are also reported in official documentation.

Q: Does Zoloft affect blood sugar levels?

Official regulatory documents note that changes in glycemic control (blood sugar levels) have been reported in some patients. Caution is warranted for individuals who may be susceptible to changes in blood glucose.

Q: Does taking Zoloft affect fertility or getting pregnant?

Regulatory documents caution that using the drug during the third trimester of pregnancy may increase the risk of a lung condition in the newborn called PPHN. Information regarding the drug's effect on human fertility is often limited or contradictory in official sources.

Q: Is there a generic version of Zoloft available?

Yes, the active ingredient in Zoloft, sertraline hydrochloride, is widely available as a generic medication, according to regulatory drug lists and resources.

Q: What ingredients are in Zoloft besides the active drug sertraline?

The active ingredient is sertraline hydrochloride. The specific inactive ingredients (excipients) in the tablet form, and the aqueous/alcoholic base used in the liquid oral concentrate solution, are detailed in the official product labeling.

How should Zoloft Pfizer be stored and disposed of?

How to Store and Dispose of Zoloft (Sertraline)

Official regulatory documents define strict conditions for the storage and disposal of Zoloft tablets and oral concentrate.

Storage Requirements

  • Temperature: Store at controlled room temperature, 68 F to 77 F (20 C to 25 C). The medication must be kept from freezing.
  • Protection: The container must be kept tightly closed and stored away from moisture and excessive heat.
  • Child Safety: All forms of Zoloft must be stored out of the reach of children.
  • Oral Concentrate Stability: The liquid concentrate must be diluted and drunk immediately; do not mix a dose and store it for later consumption.

Disposal Instructions

Unused or expired Zoloft should be discarded through a drug take-back program. If a take-back program is unavailable, mix the medicine with an undesirable substance (such as dirt) and place it in a sealed container for disposal in the household trash. Do not flush Zoloft down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zoloft Pfizer found in:

A-Z Index: